$ENDP Endo Pharmaceuticals Earnings Preview htt

$ENDP Endo Pharmaceuticals Earnings Preview



Source: NPR

Endo Pharmaceuticals (ENDP) reports quarterly earnings May 8th. Analysts expect revenue of $691.83 million and eps of $0.55. The revenue estimate implies a 30% decline Y/Y. Investors should focus on the following key items:

Diminution In Generics
There is a war being fought over rising drug prices and Endo Pharmaceuticals (ENDP) is in the middle of it. The company has gotten lumped in with price-gougers like Valeant (VRX) and Turing Pharmaceuticals who acquire brands and raise prices post-deal. The FDA and lawmakers have made concerted efforts to

Read more ...


Source: SeekingAlpha (April 30, 2018 - 6:58 AM EDT)

News by QuoteMedia
www.quotemedia.com